Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GSTC
GlobeStar Therapeutics
$0.00
$0.00
$0.00
N/A2.558,020 shsN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
$0.00
$0.00
$0.21
$36KN/A26,223 shs2,000 shs
OREXQ
Orexigen Therapeutics
$0.01
+35.9%
$0.01
$0.00
$0.16
$100K4.9880,439 shs60,300 shs
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
$0.00
$0.00
$0.00
$0.00
$79K4.92N/AN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GSTC
GlobeStar Therapeutics
0.00%0.00%0.00%-50.00%-90.00%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00%0.00%0.00%0.00%0.00%
OREXQ
Orexigen Therapeutics
0.00%0.00%0.00%0.00%0.00%
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.00%0.00%0.00%+450.00%-45.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GSTC
GlobeStar Therapeutics
0.00
N/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00
N/AN/AN/A
OREXQ
Orexigen Therapeutics
0.00
N/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
$33.71M0.00N/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
$660K0.12N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GSTC
GlobeStar Therapeutics
-$1.95MN/A0.00N/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/A0.00N/AN/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
-$24.52MN/A0.00N/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
-$750KN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
GSTC
GlobeStar Therapeutics
0.01%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
OREXQ
Orexigen Therapeutics
N/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.01%

Insider Ownership

CompanyInsider Ownership
GSTC
GlobeStar Therapeutics
2.50%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
OREXQ
Orexigen Therapeutics
13.30%
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
15.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
GSTC
GlobeStar Therapeutics
11.24 billion1.21 billionNot Optionable
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
1,70012.95 millionN/ANot Optionable
OREXQ
Orexigen Therapeutics
13218.89 millionN/ANot Optionable
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
8143.19 million120.71 millionNot Optionable

Recent News About These Companies

Cancer Wellness Center of NEPA holds Annual Walk
Wellness Center attendance up
MCCTC Plans New Health and Wellness Center
Chamber holds ribbon cutting for Women’s Wellness Center

Media Sentiment Over Time

GlobeStar Therapeutics OTCMKTS:GSTC

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

NephroGenex stock logo

NephroGenex OTCMKTS:NRXGQ

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

Orexigen Therapeutics OTCMKTS:OREXQ

$0.0053 +0.00 (+35.90%)
As of 05/31/2019

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Wellness Center Usa stock logo

Wellness Center Usa OTCMKTS:WCUI

$0.0006 0.00 (0.00%)
As of 06/27/2025

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.